RealPharma: Conversations with Pharma Pathfinders

Decoding HEOR: Iris Tam’s Insights on Pharma’s Value-Based Future


Listen Later

Join us on a deep dive into the world of Health Economics and Outcomes Research (HEOR) with the remarkable Iris Tam, PharmD, a luminary in value-based evidence generation within the biopharma industry. In this episode, our hosts Ian and Na-Ri explore with Iris the critical role of HEOR in transforming today's pharmaceutical landscape, from drug development to global marketing strategies and beyond.


Unpacking the complexities of HEOR, they delve into its definition, significance, and the evolving importance of this field in aligning drug development with payer expectations and patient outcomes. Iris shares invaluable insights on the key elements that payers scrutinize in HEOR studies, and the strategic considerations essential for successful global product launches. 


Ethical considerations in HEOR research also take center stage, highlighting the responsibility of ensuring integrity and patient-centricity in evidence generation. For professionals eager to make their mark in HEOR or advance their careers, Iris offers sage advice, emphasizing the need for robust data, the value of learning from post-mortems, and the art of using failures to forge successful future strategies.


This episode is not just an exploration of HEOR's impact on healthcare but a guide to understanding the challenges of demonstrating product value and the crucial role of user adoption. Whether you're a seasoned professional or new to the field, Iris's journey and insights offer inspiration and guidance for navigating the complexities of HEOR in the biopharma industry.


Chapters

  • 00:00 Introduction of Iris Tam


  • 02:08 Definition and Significance of HEOR


  • 04:07 Evolution and Increasing Role of HEOR


  • 07:49 Components of HEOR: Health Economics and Outcomes Research


  • 10:26 Impact of HEOR on Drug Development and Marketing Strategies


  • 25:46 Key Elements for Payers in HUR Studies


  • 38:47 Considerations for HUR in Global Launches


  • 41:35 Ethical Considerations in HUR Research


  • 46:41 Skills and Experiences for Success in HUR


  • 51:49 The importance of user adoption


  • 52:01 Learning from post mortems


  • 53:01 Using failures to inform future strategies


  • 53:55 The challenge of proving product benefits


  • 54:23 Closing thoughts and advice


Resources:

  • Iris Tam


  • Coeus Consulting Group


  • ISPOR HEOR Resources



  • ISPOR Top 10 HEOR Trends


...more
View all episodesView all episodes
Download on the App Store

RealPharma: Conversations with Pharma PathfindersBy RealPharma

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like RealPharma: Conversations with Pharma Pathfinders

View all
Wait Wait... Don't Tell Me! by NPR

Wait Wait... Don't Tell Me!

38,555 Listeners

WSJ What’s News by The Wall Street Journal

WSJ What’s News

4,324 Listeners

HBR IdeaCast by Harvard Business Review

HBR IdeaCast

1,865 Listeners

The NPR Politics Podcast by NPR

The NPR Politics Podcast

25,810 Listeners

The Daily by The New York Times

The Daily

110,870 Listeners

Bold Names by The Wall Street Journal

Bold Names

1,448 Listeners

It's Been a Minute by NPR

It's Been a Minute

8,952 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

Behind the Money by Financial Times

Behind the Money

223 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,949 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

9,252 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

F1 Nation by Formula 1

F1 Nation

757 Listeners

SmartLess by Jason Bateman, Sean Hayes, Will Arnett

SmartLess

57,565 Listeners

Hard Fork by The New York Times

Hard Fork

5,479 Listeners